comparemela.com

Latest Breaking News On - Study of drug development tufts - Page 1 : comparemela.com

CluePoints wins prestigious accolade for commitment to innovation

CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical trials has won the best Contract Research Organization (CRO) in the specialist providers category at Citeline’s 2023 SCRIP Awards.

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards RBQM leader recognized in Specialist Providers Category at Citeline’s SCRIP Awards King of Prussia, PA  – October 12th, 2023: CluePoints, the prem.

The Need For Adaptive Trial Design In Oncology Studies

Even with thousands of pharmaceutical trials currently underway across the globe, oncology trials are still presenting more difficulty to sponsors.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.